Theranostic applications of phage display to control leishmaniasis: Selection of biomarkers for serodiagnostics, vaccination, and immunotherapy

Phage display is a high-throughput subtractive proteomic technology used for the generation and screening of large peptide and antibody libraries. It is based on the selection of phage-fused surface-exposed peptides that recognize specific ligands and demonstrate desired functionality for diagnostic...

Descripción completa

Detalles Bibliográficos
Autores: Goulart, Luiz Ricardo, Soto Álvarez, Manuel, Tavares, Carlos Alberto Pereira, Costa, Lourena Emanuele, Chávez-Fumagalli, Miguel Angel, Coelho, Eduardo Antonio Ferraz
Tipo de recurso: artículo
Fecha de publicación:2015
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/675362
Acceso en línea:http://hdl.handle.net/10486/675362
https://dx.doi.org/10.1590/0037-8682-0096-2015
Access Level:acceso abierto
Palabra clave:Mimotopes
Phage display
Serodiagnosis
Vaccine
Visceral leishmaniasis
Biología y Biomedicina / Biología
Descripción
Sumario:Phage display is a high-throughput subtractive proteomic technology used for the generation and screening of large peptide and antibody libraries. It is based on the selection of phage-fused surface-exposed peptides that recognize specific ligands and demonstrate desired functionality for diagnostic and therapeutic purposes. Phage display has provided unmatched tools for controlling viral, bacterial, fungal, and parasitic infections, and allowed identification of new therapeutic targets to treat cancer, metabolic diseases, and other chronic conditions. This review presents recent advancements in serodiagnostics and prevention of leishmaniasis -an important tropical parasitic disease- achieved using phage display for the identification of novel antigens with improved sensitivity and specificity. Our focus is on theranostics of visceral leishmaniasis with the aim to develop biomarker candidates exhibiting both diagnostic and therapeutic potential to fight this important, yet neglected, tropical disease